ClinicalTrials.gov
ClinicalTrials.gov Menu

Insulin Resistance as Primary Pathogenesis in Newly Diagnosed, Drug naïve Type 2 Diabetes Patients in Korea (SURPRISE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01154244
Recruitment Status : Completed
First Posted : June 30, 2010
Last Update Posted : January 25, 2011
Sponsor:
Information provided by:
GlaxoSmithKline

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2010
  Actual Study Completion Date : July 2010